Showing 1 - 10 of 7,565
Chapter 1. Introduction -- Chapter 2. A Profile of the Indian Pharmaceutical Companies -- Chapter 3. Marketing Activities of Indian Pharmaceutical Companies -- Chapter 4. Research and Development Activities of the Indian Pharmaceutical Companies -- Chapter 5. Global Competitiveness of Indian...
Persistent link: https://www.econbiz.de/10012814655
Pharmaceutical Economics begins with an investigation of the structure of the industry and its three main components: the research firms which produce innovative products; the generic drug industry and its expanding role; and the biotech industry, which is regarded as the future for...
Persistent link: https://www.econbiz.de/10011852149
Persistent link: https://www.econbiz.de/10010219298
Persistent link: https://www.econbiz.de/10013326811
öffentliche Diskussion über Rolle und Verantwortung der Pharmaindustrie. Die Unternehmensverantwortlichen müssen sich daher mit … Nachhaltigkeit für die Pharmaindustrie. Er zeigt, dass die aktuellen Nachhaltigkeitsprobleme aufgrund unterschiedlicher Zusammenhänge …
Persistent link: https://www.econbiz.de/10013516620
Einführung in das Thema -- Aktuelle Patentausläufe und die an ihnen beteiligten Unternehmen -- Theoretische und empirische Grundlagen -- Der Produktlebenszyklus von Arzneimitteln -- Die Rolle von Patenten in der pharmazeutischen Industrie -- Auswirkungen von Patentausläufen in der...
Persistent link: https://www.econbiz.de/10013517082
As business processes are crucial success factors for companies, software-based Business Process Management (BPM) is becoming more and more important. In this area SAP, the market leader for enterprise application software, has already gathered substantial experience. For the characterization,...
Persistent link: https://www.econbiz.de/10014017133
Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model...
Persistent link: https://www.econbiz.de/10014017144
Deals with the topic of out-licensing as a novel form of risk-sharing collaborations. The phenomenon of out-licensing is illustrated by three major case studies of Novartis, Schering and Roche as well as several smaller case studies. This book applies the Nobel Prize awarded economic theory of...
Persistent link: https://www.econbiz.de/10013520588
Persistent link: https://www.econbiz.de/10013520901